Former FDA Commissioner Dr. Scott Gottlieb joins Squawk Box to discuss Amgens new injectable weight loss drugs, how it takes a different approach







Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better [5Jtm5Gsuecd]

Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better [5Jtm5Gsuecd]

| 1h 28m 28s | Video has closed captioning.

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Amgen's new injectable weight loss drugs, how it takes a different approach from other weight loss drugs like Wegovy and Mounjaro, state of the obesity drug market, and more.

Aired: December 12, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better [5Jtm5Gsuecd] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better [5Jtm5Gsuecd] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better [5Jtm5Gsuecd] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now